ShareofCost.com – Toxic Trio Identified As The Basis Of Celiac Disease
Wednesday, Jan. 19th 2022 1:47 PM
Walter and Eliza Hall Institute scientists have identified the three protein fragments that make gluten – the main protein in wheat, rye and barley – toxic to people with coeliac disease. Their discovery opens the way for a new generation of diagnostics, treatments, prevention strategies and food tests for the millions of people worldwide with coeliac disease…
Related posts:
- Share of Cost, Celiac Disease Share of Cost, Celiac Disease...
- Share of Cost, New Regulator Identified In Allergic Diseases Share of Cost, New Regulator Identified In Allergic Diseases...
- Share of Cost, Alzheimer’s Disease Share of Cost, Alzheimer’s Disease...
- Alzheimer’s Disease – Share of Cost Today at least 5.5 million Americans have Alzheimer’s disease or another form of dementia, and that number only continues to grow. A recent study conducted by the Rand Corporation revealed that by the year 2019, nearly 15 million Americans will be living with mild cognitive impairment, which could be an early sign of Alzheimer’s disease. […]...
- How Does Alzheimer’s Disease Develop? A second pathway through which Alzheimer’s develops has been discovered after researchers identified a new set of genetic markers for the disease. Most Alzheimer’s genetic research focuses on amyloid-beta, which contributes to the formation of plaques found in the brains of people suffering from Alzheimer’s. In this study, published in the journal Neuron, researchers were […]...
- Share of Cost, How Does Alzheimer’s Disease Develop? Share of Cost, How Does Alzheimer's Disease Develop? ...
- Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment Share of Cost, Fresh Funding Gives Hope To A New Generation Of Asthma And Allergy Treatment...
- ShareofCost.com – Acid Reflux Disease The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease (GERD) is not as high as many may think, according to new research from University of Michigan gastroenterologists. GERD is considered a relative risk for developing esophageal adenocarcinoma, but the absolute risk is not known, says Joel Rubenstein, M.D., M.Sc....
- No to oligarchy: The American people are hurting The American people are hurting. As a result of the greed, recklessness and illegal behavior on Wall Street, millions of Americans have lost their jobs, homes, life savings and their ability to get a higher education. Today, some 22 percent of our children live in poverty, and millions more have become dependent on food stamps […]...
- Share of Cost, Following Centers for Disease Control Protocols Cuts Dialysis Bloodstream Infections In Half Share of Cost, Following Centers for Disease Control Protocols Cuts Dialysis Bloodstream Infections In Half...
- Share of Cost, Simple, sensitive, and cost-effective assays for analyzing fragile X Share of Cost, Simple, sensitive, and cost-effective assays for analyzing fragile X...
- Share of Cost, Genomic testing can help identify patients at heightened risk for esophageal cancer Share of Cost, Genomic testing can help identify patients at heightened risk for esophageal cancer...
- Share of Cost, The Affordable Care Act May Increase The Number Of People Getting Tested For HIV By Nearly 500,000 By 2017 People are much less likely to engage in risky sexual behavior if they know that they are HIV-positive. Unfortunately, more than 18 percent of people living with HIV/AIDS in the United States are unaware of their HIV status, and about half of new HIV infections are transmitted from that “HIV unaware” population. For these reasons, HIV […]...
- Share of Cost, Stress-related protein speeds progression of Alzheimer’s disease Share of Cost, Stress-related protein speeds progression of Alzheimer's disease...
- Share of Cost on How Gum Disease Effects The Rest of Your Health Share of Cost on How Gum Disease Effects The Rest of Your Health...
Posted on Wednesday, Jan. 19th 2022 1:47 PM | by Share of Cost | in Share of Cost | No Comments »